Hypertension, a condition characterized by elevated blood pressure, poses a significant medical risk, particularly in relation to the development of cardiovascular disease. The pathogenesis of hypertension can be influenced by a combination of genetic and environmental factors. Recent scientific studies have shed light on the involvement of long-non-coding RNAs (lncRNAs) in various diseases, including pulmonary arterial and essential hypertension. These lncRNAs have been found to play crucial roles at the transcriptional, post-transcriptional, and post-translational levels. By targeting endothelial cell proliferation, migration, apoptosis, and angiogenesis, lncRNAs can induce dysfunction in arterial endothelial cells, contributing to the progression of hypertension-related pathological events. Therefore, the abnormal expression of lncRNAs has emerged as a significant factor in the understanding of essential hypertension and its associated mechanisms. To further our understanding, we conducted a comprehensive review focusing on unraveling the functional roles of lncRNAs in essential hypertension.
No takes yet. Share an insight, caveat, or question.
Azizidoost et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: